Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.
Reported portfolio value by quarter (4 quarters reported)
$13M in Q4 2021 → — now. Hover for any quarter.
As reported for the quarter ended September 30, 2022. Activity is the change in share count since the prior quarter's filing.
| Holding | % of portfolio | Activity | Shares | Value |
|---|---|---|---|---|
| N N/a | NaN% | New | 0 | — |
What changed each quarter, from the filings' own share counts. Largest moves first; most recent 3 quarters.
quarter ended September 30, 2022 · filed October 21, 2022
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| IM I Mab | Exited | −2,054 | −$23K | — |
| N N/a | New | +0 | — | — |
quarter ended June 30, 2022 · filed July 25, 2022
No position changes this quarter.
quarter ended March 31, 2022 · filed May 04, 2022
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| IM I Mab | Trimmed | −197,946 | −$3.18M | 100.0% |
| Zai Lab Ltd | Exited | −28,952 | −$1.82M | — |
| Burning Rock Biotech Ltd | Exited | −174,403 | −$1.66M | — |
Loading...
